Used in biomedical research to quantify levels of Glyoxalase 1 (GLO1) protein in human biological samples such as serum, plasma, and cell lysates. This kit enables researchers to study the role of GLO1 in cellular detoxification processes, particularly its involvement in the removal of methylglyoxal, a cytotoxic byproduct of glycolysis. It is widely applied in studies related to diabetes and its complications, as elevated methylglyoxal levels are associated with diabetic neuropathy, nephropathy, and retinopathy. The kit also supports research in cancer biology, where GLO1 overexpression has been linked to drug resistance and tumor cell survival. Additionally, it is used in neuroscience to investigate GLO1's potential role in anxiety disorders and neurodegenerative diseases. The assay provides a reliable, sensitive, and high-throughput method for measuring GLO1 in experimental and clinical investigations.